drugset / Trial / NCT03360123

Comparison of Triazolam and Midazolam for Anxiolysis During Dental Treatment in the Pediatric Patient

NCT03360123

Completed 4 enrolled University of Pittsburgh
RandomizedCrossoverOpen-labelOther

Summary

This study will evaluate the perceptions of the effects of two anxiolytic medications commonly used during dental treatment in patients weighing 40 kilograms or more.

Timeline

Start
2018-01-26
Primary completion
2018-04-11
Completion
2018-04-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 0.5 mg/kg Oral
Comparator Triazolam Small molecule 0.125 mg Oral

Indications

No indication recorded.